Sign in

CIK 0000318154 · Large accelerated filer

Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
953540776
Phone
(805)447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 8-K Event Regulation FD disclosure · Other events
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale EVP, Global Commercial Ops sold 9,558 shares at $262.43 ($2,508,306)
  4. 4 Grant or award Director acquired 153.37 shares (grant or award)
  5. 4 Grant or award Director acquired 124.62 shares (grant or award)
  6. 4 Grant or award Director acquired 124.62 shares (grant or award)
  7. 144 Insider Sale of Securities
  8. 10-Q Report Quarterly Report
  9. 8-K Event Executive or director change
  10. 8-K Event Results of operations
  11. 4 Shares withheld for taxes SVP & CCO gave up 1,129 shares (to pay taxes)
  12. 11-K Other Annual Report
  13. 11-K Other Annual Report
  14. 8-K Event Other events
  15. 4 Grant or award Director acquired 939 shares (grant or award)
  16. 4 Grant or award Director acquired 939 shares (grant or award)
  17. 4 Grant or award Director acquired 939 shares (grant or award)
  18. 4 Grant or award Director acquired 939 shares (grant or award)
  19. 4 Grant or award Director acquired 939 shares (grant or award)
  20. 4 Grant or award Director acquired 939 shares (grant or award)

Page 20 of 161 · 3,201 filings